Therapy with interleukin-22 alleviates hepatic injury and hemostasis dysregulation in rat model of acute liver failure

Advances in Hematology

Volumn 2014, Issue , 2014, Pages

  Ashour, Tariq Helal ^a  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOOXYGENASE 2; FIBRINOGEN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE COUNT; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; IMMUNOTHERAPY; INFLAMMATORY CELL; LEUKOCYTE; LEUKOCYTE COUNT; LIVER FUNCTION; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MORTALITY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RAT; RAT MODEL; SURVIVAL RATE; THROMBOCYTE COUNT;

EID: 84899563460     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2014/705290     Document Type: Article

References (31)

1. Lee W. M., Acute liver failure. Seminars in Respiratory and Critical Care Medicine 2012 33 36 45
2. Wu F., Wang M., Tian D., Serum from patients with hepatitis E virus-related acute liver failure induces human liver cell apoptosis. Experimental and Therapeutic Medicine 2014 7 1 300 304
3. Simonian P. L., Wehrmann F., Roark C. L., Born W. K., O'Brien R. L., Fontenot A. P., γ δ T cells protect against lung fibrosis via IL-22. Journal of Experimental Medicine 2010 207 10 2239 2253 2-s2.0-77957736967 10.1084/jem.20100061
4. Wu P. W., Li J., Kodangattil S. R., Luxenberg D. P., Bennett F., Martino M., Collins M., Dunussi-Joannopoulos K., Gill D. S., Wolfman N. M., Fouser L. A., IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. Journal of Molecular Biology 2008 382 5 1168 1183 2-s2.0-51349156105 10.1016/j.jmb.2008.07.046
5. Kumar P., Rajasekaran K., Palmer J. M., Thakar M. S., Malarkannan S., IL-22: an evolutionary missing-link authenticating the role of the immune system in tissue regeneration. Journal of Cancer 2013 4 1 57 65
6. Zenewicz L. A., Flavell R. A., Recent advances in IL-22 biology. International Immunology 2011 23 3 159 163 2-s2.0-79952584368 10.1093/intimm/dxr001
7. Ren X., Hu B., Colletti L. M., IL-22 is involved in liver regeneration after hepatectomy. The American Journal of Physiology: Gastrointestinal and Liver Physiology 2010 298 1 G74 G80 2-s2.0-73549109368 10.1152/ajpgi.00075.2009
8. Xing W.-W., Zou M.-J., Liu S., Xu T., Wang J.-X., Xu D.-G., Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice. Bioscience, Biotechnology and Biochemistry 2011 75 7 1290 1294 2-s2.0-79960769980 10.1271/bbb.110061
9. Kong X., Feng D., Wang H., Hong F., Bertola A., Wang F. S., Gao B., Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis. Hepatology 2012 56 3 1150 1159
10. Feng D., Kong X., Weng H., Park O., Wang H., Dooley S., Gershwin M. E., Gao B., Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic HBV infection. Gastroenterology 2012 143 1 188.e7 198.e7
11. Xiang X., Gui H., King N. J., Cole L., Wang H., Xie Q., Bao S., IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunology and Cell Biology 2012 90 611 619 2-s2.0-80053347359 10.1038/icb.2011.79
12. Kong X., Feng D., Mathews S., Gao B., Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. Journal of Gastroenterology and Hepatology 2013 28 1 56 60
13. Institute of Laboratory Animal Resources, Guide for the Care and Use of Laboratory Animals 1996 7th Washington, DC, USA Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council
14. Liu L.-M., Zhang J.-X., Luo J., Guo H.-X., Deng H., Chen J.-Y., Sun S.-L., A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats. Digestive Diseases and Sciences 2008 53 5 1316 1324 2-s2.0-41949092339 10.1007/s10620-007-9994-y (Pubitemid 351514647)
15. Lemini C., Jaimez R., Franco Y., Gender and inter-species influence on coagulation tests of rats and mice. Thrombosis Research 2007 120 3 415 419 2-s2.0-34250023158 10.1016/j.thromres.2006.10.012 (Pubitemid 46881257)
16. Han D.-W., Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World Journal of Gastroenterology 2002 8 6 961 965 2-s2.0-0036898055 (Pubitemid 35446402)
17. Dong L., Zuo L., Xia S., Gao S., Zhang C., Chen J., Zhang J., Reduction of liver tumor necrosis factor- α expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis. Journal of Gene Medicine 2009 11 3 229 239 2-s2.0-65349087883 10.1002/jgm.1293
18. Sass G., Heinlein S., Agli A., Bang R., Schümann J., Tiegs G., Cytokine expression in three mouse models of experimental hepatitis. Cytokine 2002 19 3 115 120 2-s2.0-0036401433 10.1006/cyto.2002.1948 (Pubitemid 35216191)
19. Korish A. A., Effect of caffeic acid phenethyl ester on the hemostatic alterations associated with toxic-induced acute liver failure. Blood Coagulation and Fibrinolysis 2010 21 2 158 163 2-s2.0-76449112616 10.1097/MBC. 0b013e32833678be
20. Pan H., Hong F., Radaeva S., Gao B., Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cellular & Molecular Immunology 2004 1 1 43 49 2-s2.0-2342458559
21. Radaeva S., Sun R., Pan H.-N., Hong F., Gao B., Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004 39 5 1332 1342 2-s2.0-2342462460 10.1002/hep.20184 (Pubitemid 38569055)
22. Yang L., Zhang Y., Wang L., Fan F., Zhu L., Li Z., Ruan X., Huang H., Wang Z., Huang Z., Huang Y., Yan X., Chen Y., Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. Journal of Hepatology 2010 53 2 339 347 2-s2.0-77955308513 10.1016/j.jhep.2010.03.004
23. Liang S. C., Nickerson-Nutter C., Pittman D. D., Carrier Y., Goodwin D. G., Shields K. M., Lambert A.-J., Schelling S. H., Medley Q. G., Ma H.-L., Collins M., Dunussi-Joannopoulos K., Fouser L. A., IL-22 induces an acute-phase response. Journal of Immunology 2010 185 9 5531 5538 2-s2.0-78149487314 10.4049/jimmunol.0904091
24. Wu Z., Kong X., Zhang T., Ye J., Fang Z., Yang X., Pseudoephedrine/ ephedrine shows potent anti-inflammatory activity against TNF-alpha-mediated acute liver failure induced by lipopolysaccharide/d-galactosamine. European Journal of Pharmacology 2014 724 112 121
25. Waage A., Beutler B., Presence and involvement of TNF-alpha in septic shock. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine 1993 New York, NY, USA Raven Press 275 283
26. Jaeschke H., Gores G. J., Cederbaum A. I., Hinson J. A., Pessayre D., Lemasters J. J., Mechanisms of hepatotoxicity. Toxicological Sciences 2002 65 2 166 176 2-s2.0-0036163759 10.1093/toxsci/65.2.166 (Pubitemid 34121108)
27. Dejager L., Libert C., Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice. Cytokine 2008 42 1 55 61 2-s2.0-41149083879 10.1016/j.cyto.2008.01.014
28. Chang H., Hanawa H., Liu H., Yoshida T., Hayashi M., Watanabe R., Abe S., Toba K., Yoshida K., Elnaggar R., Minagawa S., Okura Y., Kato K., Kodama M., Maruyama H., Miyazaki J., Aizawa Y., Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. Journal of Immunology 2006 177 6 3635 3643 2-s2.0-33748500234 (Pubitemid 44359895)
29. Kang Y.-J., Wingerd B. A., Arakawa T., Smith W. L., Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. Journal of Immunology 2006 177 11 8111 8122 2-s2.0-33751578405 (Pubitemid 44846330)
30. Ganey P. E., Barton Y.-W., Kinser S., Sneed R. A., Barton C. C., Roth R. A., Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide. Toxicology and Applied Pharmacology 2001 174 2 113 121 2-s2.0-0035878880 10.1006/taap.2001.9183 (Pubitemid 32675513)
31. Han C., Li G., Lim K., DeFrances M. C., Gandhi C. R., Wu T., Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure. Journal of Immunology 2008 181 11 8027 8035 2-s2.0-58149277371